Heparanases: Endoglycosidases that degrade heparan sulfate proteoglycans

Glycobiology

Volumn 11, Issue 6, 2001, Pages

  Bame, K J ^a  

^a UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

Author keywords

Catabolism; Heparan Sulfate; Heparanase; Proteoglycans

Indexed keywords

CORE PROTEIN; GLYCOSAMINOGLYCAN; GLYCOSIDASE; HEPARANASE; OLIGOSACCHARIDE; PROTEOHEPARAN SULFATE;

ANGIOGENESIS; ANIMAL CELL; ANIMAL TISSUE; BASEMENT MEMBRANE; CATABOLISM; CELL PROLIFERATION; CELL SECRETION; CHO CELL; CONTROLLED STUDY; DEGRADATION; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME ASSAY; ENZYME PURIFICATION; ENZYME RELEASE; ENZYME SPECIFICITY; EXTRAVASATION; IMMUNOCOMPETENT CELL; INFLAMMATION; INJURY; INTRACELLULAR TRANSPORT; LYSOSOME; NONHUMAN; PLACENTA; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; THROMBOCYTE;

EID: 0034937208     PISSN: 09596658     EISSN: None     Source Type: Journal    
DOI: 10.1093/glycob/11.6.91R     Document Type: Review

References (72)

1. Molecular cloning and expression of a third member of the heparan sulfate/heparin GlcNAc N-deacetylase/N-sulfotransferase family
2. An animal cell mutant defective in heparan sulfate hexuronic acid 2-O-sulfation
3. Turnover of heparan sulfate depends on 2-O-Sulfation of uronic acids
4. Release of heparan sulfate glycosaminoglycans from proteoglycans in Chinese hamster ovary cells does not require proteolysis of the core protein
5. Undersulfated heparan sulfate in a Chinese hamster ovary cell mutant defective in heparan sulfate N-sulfotransferase
6. Heparanases produce distinct populations of heparan sulfate glycosaminoglycans in Chinese hamster ovary cells
7. Aβ(1-40) prevents heparanase-catalyzed degradation of heparan sulfate glycosaminoglycans and proteoglycans in vitro. A role for heparan sulfate proteoglycan turnover in Alzheimer's disease
8. Partial purification of heparanase activity in Chinese hamster ovary cells. Evidence for multiple heparanases
9. The spacing of S-domains on HS glycosaminoglycans determines whether the chain is a substrate for intracellular heparanases
10. Functions of cell surface heparan sulfate proteoglycans
11. Histidine-proline-rich glycoprotein as a plasma pH sensor. Modulation of its interaction with glycosaminoglycans by pH and metals
12. 4Cl-treated normal cells
13. Structural comparison of fibroblast growth factor-specific heparan sulfates derived from a growing or differentiated neuro-epithelial cell line
14. The FERM domain: A unique module involved in the linkage of cytoplasmic proteins to the membrane
15. Heparanase expression in invasive trophoblasts and acute vascular damage
16. Normal development of mice and unimpaired cell adhesion/cell mortality/actin-based cytoskeleton without compensatory up-regulation of ezrin or radixin in moesin gene knockout
17. Glypican (heparan sulfate proteoglycan) is palmitoylated, deglycanated and reglycanated during recycling in skin fibroblasts
18. Processing of the human heparanase precursor, and evidence that the active enzyme is a heterodimer
19. Age-dependent modulation of heparan sulfate structure and function
20. Human platelet heparanase: Purification, characterization and catalytic activity
21. Molecular behavior adapts to context: Heparanase functions as an extracellular matrix-degrading enzyme or as a T Cell adhesion molecule, depending on the local pH
22. Partial sequence of human platelet heparitinase and evidence of its ability to polymerize
23. Purification and characterization of placental heparanase and its expression by cultured cytotrophoblasts
24. Comparison of the heparanase enzymes from mouse melanoma cells, mouse macrophages, and human platelets
25. Regulation mechanism of ERM protein/plasma membrane association: Possible involvement of phosphatidyl turnover and Rho-dependent signalling pathway
26. CXC chemokines connective tissue activating peptide-III and neutrophil activating peptide-2 are heparin/heparan sulfate-degrading enzymes
27. A heparan sulfate-degrading endoglycosidase form rat liver tissue
28. Cloning of mammalian heparanase, an important enzyme in tumor invasion and metastasis
29. Regulation of platelet heparanase during inflammation: Role of pH and proteinases
30. The biology of perlecan: The multifaceted heparan sulphate proteoglycan of basement membranes and pericellular matrices
31. Chemically modified heparins as inhibitors of heparan sulfate specific endo-β-glucuronidase (heparanase) of metastatic melanoma cells
32. Heparanase activity expressed in platelets, neutrophils, and lymphoma cells releases active fibroblast growth factor from extracellular matrix
33. Substrate specificity of a heparan sulfate-degrading endoglucuronidase from human placenta
34. Glycosaminoglycan degradation
35. Cloning and functional expression of a human heparanase gene
36. Production of heparanase by normal and neoplastic murine B-lymphocytes
37. Inhibition of T lymphocyte heparanase by heparin prevents T cell migration and T cell-mediated immunity
38. Regulated diversity of heparan sulfate
39. Polysaccharide lyases
40. A heparin-binding synthetic peptide of heparin/heparan sulfate-interacting protein modulates blood coagulation activities
41. Bio-specific sequences and domains in heparan sulphate and the regulation of cell growth and adhesion
42. Remnant lipoprotein metabolism: Key pathways involving cell-surface heparan sulfate proteoglycans and apolipoprotein E
43. Heparanase and a synthetic peptide of heparan sulfate-interacting protein recognize common sites on cell surface and extracellular matrix heparan sulfate
44. Degradation of heparan sulfate in the subendothelial matrix by readily released heparanase from human neutrophils
45. Cloning and expression profiling of Hpa2, a novel mammalian heparanase family member
46. Changes in glycosaminoglycan structure and composition of the main heparan sulphate proteoglycan from human colon carcinoma cells (perlecan) during cell differentiation
47. Metabolism of receptor-bound and matrix-bound basic fibroblast growth factor by bovine endothelial cells
48. The effect of variation of substitution on the solution conformation of heparin: A spectroscopic and molecular modeling study
49. Conformation and dynamics of heparin and heparan sulfate
50. Metastatic melanoma cell heparanase. Characterization of heparan sulfate degradation fragments produced by B16 melanoma endoglucuronidase
51. Cleavage of macromolecular heparin by an enzyme from mouse mastocytoma
52. Characterization of a platelet endoglycosidase degrading heparin-like polysaccharides
53. Purification and properties of human platelet heparitinase
54. Treatment of central nervous system inflammation with inhibitors of basement membrane degradation
55. Maintenance on extracellular matrix and expression of heparanase activity by human ovarian carcinoma cells from biopsy specimens
56. Substrate specificity of heparanase from human hepatoma and platelets
57. Endothelial cell heparanase modulation of lipoprotein lipase. Evidence that heparan sulfate oligosaccharide is an extracellular chaperone
58. Structure and bioactivity of recombinant human CTAP-III and NAP-2
59. A cellulose-binding domain-fused recombinant human T Cell connective tissue-activating peptide-III manifests heparanase activity
60. Human mononuclear cells contain an endoglycosidase specific for heparan sulphate glycosaminoglycan demonstrable with the use of a specific solid-phase metabolically radiolabelled substrate
61. An important role of heparan sulfate proteoglycan (perlecan) in a model system for the deposition and persistence of fibrillar Aβ-amyloid in rat brain
62. Heparan sulfate proteoglycans control intracellular processing of bFGF in vascular smooth muscle cells
63. Enzymatic depolymerization of heparin-related polysaccharides. Substrate specificities of mouse mastocytoma and human platelet endo-β-D-glucuronidases
64. Human heparanase. Purification, characterization, cloning and expression
65. Cortical actin organization: Lessons from ERM (ezrin/radixin/moesin) proteins
66. The interaction between basic fibroblast growth factor and heparan sulfate can prevent the in vitro degradation of the glycosaminoglycan by Chinese hamster ovary cell heparanases
67. bFGF does not prevent heparan sulphate proteoglycan catabolism in intact cells, but it alters the distribution of the glycosaminoglycan degradation products
68. Mammalian heparanase: Gene cloning, expression and function in tumor progression and metastasis
69. Syndecan proteins and cell adhesion
70. Demonstration of glycosaminoglycans in Caenorhabiditis elegans
71. Cell surface heparan sulfate proteoglycans